Table 4.
Effect of COVID-19 and other covariatesa on DS-TB treatment success in the incarcerated and non-incarcerated population (adjusted odds ratios for treatment success from logistic regression, using imputedb values for missing covariates).
All |
Non-incarcerated |
Incarcerated |
|||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | OR | 95%CI | OR | 95%CI | ||||
COVID-19 period: (Ref = TB care pre-COVID-19) | |||||||||
TB care fully during COVID-19 | 0.82 | 0.78 | 0.85 | 0.81 | 0.78 | 0.85 | 0.88 | 0.76 | 1.01 |
TB care partially during COVID-19 | 0.93 | 0.89 | 0.98 | 0.94 | 0.89 | 0.98 | 0.91 | 0.77 | 1.08 |
Sex, male (Ref = female) | 0.81 | 0.77 | 0.84 | 0.79 | 0.76 | 0.82 | 0.93 | 0.40 | 2.16 |
HIV positive | 0.43 | 0.40 | 0.46 | 0.43 | 0.40 | 0.47 | 0.69 | 0.50 | 0.94 |
Diabetes | 0.98 | 0.92 | 1.04 | 0.99 | 0.93 | 1.06 | 0.74 | 0.52 | 1.04 |
Extrapulmonary TB | 1.40 | 1.33 | 1.47 | 1.38 | 1.31 | 1.45 | 2.13 | 1.64 | 2.76 |
Type of case: (Ref = new case) | |||||||||
Previous TB treatment stopped or failed | 0.38 | 0.35 | 0.41 | 0.40 | 0.36 | 0.44 | 0.54 | 0.35 | 0.84 |
Relapse | 0.78 | 0.74 | 0.83 | 0.72 | 0.68 | 0.77 | 0.79 | 0.69 | 0.90 |
Smoking | 0.86 | 0.81 | 0.91 | 0.61 | 0.56 | 0.66 | 1.03 | 0.91 | 1.16 |
Insurance type: (Ref = private insurance) | Insurance type: (Ref = employer's insurance)c | ||||||||
Employer's insuranced | 0.76 | 0.54 | 1.08 | 0.75 | 0.53 | 1.06 | |||
Public insurancee | 0.67 | 0.48 | 0.95 | 0.64 | 0.45 | 0.90 | 0.83 | 0.19 | 3.71 |
None | 0.68 | 0.48 | 0.97 | 0.69 | 0.49 | 0.97 | 1.49 | 0.26 | 8.38 |
Good adherence ( ≥ 80% of expected doses taken) | 7.90 | 7.46 | 8.38 | 7.52 | 7.09 | 7.98 | 18.71 | 12.88 | 27.18 |
For (non-linear) effect of age covariate, see Fig. 6.
Via multiple imputation by chained equations (MICE).
None with private insurance in incarcerated population.
Seguro Social de Salud (EsSalud) or police/armed forces.
Seguro Integral de Salud (SIS).